Novatron OY
USPTO PatentsView assignee record - 10 granted patents across 13 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: E02F (DREDGING; Soil-shifting).
The verdict
According to USPTO PatentsView, Novatron ranks #27,000 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 13 technology areas.
- #27,000
- of 49,997 US assignees by volume
- Top 37%
- by Innovation Score (39.9/100)
- 14.8
- avg claims per patent
- +800%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R27000 · Foreign Corporation #27,000 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 10 grants
- MID-PACK #27,000/49,997
- PHOTO-FINISH North & South…
- CPC-FOCUS E02F · 13 areas
- INNOV-THIN 39.9/100
- CLAIMS-RICH 14.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +800% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: North & South Brother Pharmacy Investment Company Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Novatron’s 39.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Novatron
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Novatron OY · this assignee
Novatron OY · this assignee
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Novatron's Innovation Score is 39.9/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Novatron?
Each dot is one of Novatron’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novatron’s own 14.8 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Novatron's grants concentrate
Novatron OY is a focused PatentsView assignee: 13 CPC subclasses with 80% of grants classified under E02F (DREDGING; Soil-shifting). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2019. By volume, Novatron sits between North & South Brother Pharmacy Investment Company Limited and NSS Lab Works LLC.
Novatron's three-year grant acceleration
Novatron OY shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Novatron's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- North & South Bro…
North & South Brother Pharmacy Investment Company Limited
10 patents
- Novabiotics
Novabiotics Limited
10 patents
- Novabone Products
Novabone Products, LLC
10 patents
- Novastep
Novastep
10 patents
- Novenco A/S
Novenco A/S
10 patents
- Novoxel
Novoxel Ltd
10 patents
- Nsfocus
Nsfocus Technologies, Inc.
10 patents
- NSS Lab Works
NSS Lab Works LLC
10 patents
- Novatron OY ◀
Novatron OY
10 patents
What this shows Novatron holds 10 patents at rank #26,948, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Novatron
By rank, the assignees closest to #26,948 in granted patent volume.
- North & South Brother Pharmacy Investment Company Limited #26,944 · 10 patents
- Novabiotics Limited #26,945 · 10 patents
- Novabone Products, LLC #26,946 · 10 patents
- Novastep #26,947 · 10 patents
- Novenco A/S #26,949 · 10 patents
- Novoxel Ltd #26,950 · 10 patents
- Nsfocus Technologies, Inc. #26,951 · 10 patents
- NSS Lab Works LLC #26,952 · 10 patents
Leaders in E02F (Dredging)
Other assignees with the most granted patents in Novatron's primary technology class.
- Caterpillar Inc. 1,041 in class
- Komatsu Ltd. 910 in class
- Hitachi Construction Machinery Co., Ltd. 595 in class
- Deere & Company 487 in class
- Kubota Corporation 320 in class
- Kobelco Construction Machinery Co., Ltd 250 in class
- Volvo Construction Equipment AB 198 in class
- CNH Industrial America LLC 178 in class
Novatron's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 10.0% |
| 2020 | 2 | 20.0% |
| 2021 | 1 | 10.0% |
| 2022 | 2 | 20.0% |
| 2023 | 3 | 30.0% |
| 2024 | 1 | 10.0% |
Which technologies does Novatron OY patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Novatron OY's patent record in context - here's where to go next.
- Novatron OY's lead technology class is E02F (DREDGING; Soil-shifting), 80% of its portfolio - see every assignee active in that class. Explore E02F
- Ranked #27,000 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Novatron OY against North & South Brother Pharmacy Investment Company Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.